| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00018304 |
Purpose
The overall objective of this proposal is to examine the contribution of changes in total body fat, enhancement in insulin-mediated vasodilatation and enhancement in endothelium-derived nitric oxide production to the improvements in metabolic insulin action. In addition, the study will track whether these improvements are related to changes in blood pressure.
| Condition | Phase |
|
Hypertension |
Phase I |
| MedlinePlus related topics: | High Blood Pressure |
| Drug Information available for: | Insulin |
| Study Type: | Observational |
| Study Design: | Natural History |
| Official Title: | Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow |
Eligibility
| Ages Eligible for Study: | 50 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Age 50 - 75 years, elevated blood pressure, BMI greater than 25 but less than 40 kg/m2
Contacts and Locations More Information
| Study ID Numbers: | AGCG-005-98S |
| First Received: | July 3, 2001 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00018304 |
| Health Authority: | United States: Federal Government |
|
|
|
|
